Episode overview
In this episode, host Cher Pastore is joined by Dr. Jessica Castle and Dr. Stayce Beck to discuss the process behind the formulation and execution of continuous glucose Mmnitoring (CGM) accuracy trials.
The trio discuss the influence of rigorous trial design and transparency on the accuracy of CGM devices, particularly those developed by Dexcom. They highlight the importance of CGM research credibility, strategies to minimize bias, and the essential role that regulatory bodies play in ensuring quality health research. The discussion also covers the dynamics of conflicts of interest, patient and healthcare provider education, and the significance of detailed metrics for evaluating CGM performance.
Our expert panel also take us behind the scenes to reveal the meticulous work involved in creating and executing CGM studies that encompass different populations and conditions. You’ll hear discussions around key performance metrics in a CGM accuracy study, understanding why blood glucose monitor and CGM readings might not match and the explanation of relative difference and CGM accuracy.
The conversation highlights the comprehensive journey towards ensuring users can trust their CGM readings, right from day one to real-world applications.
Finally, listen as they walk us through the process of bringing transparency to CGM data analysis, alongside discussing the potential challenges and future of CGM device application in pediatric hospital discharge programs, probing into the potential barriers and challenges faced by healthcare providers and patients.
